Friday - May 17, 2019
Bayer is a main sponsor of the IUPAC International Congress of Crop Protection in Belgium:

Industry experts and scientists will discuss strategies for future weed, disease and pest control in agriculture

download
A researcher assessing soy plants.

Monheim, May 17, 2019 – Bayer has joined the 14th IUPAC (International Union of Pure and Applied Chemistry) International Congress of Crop Protection, the world’s leading event in that field, as one of the main sponsors. About 1,500 crop health specialists are expected to participate at the event in Ghent, Belgium, from May 19 to 24, 2019. Amongst them are world-renowned speakers, academia, experts from the industry, policymakers and other stakeholders.

In different panels, the experts will discuss ideas for modern crop protection, which is still largely depending on the judicious application of agrochemicals to control invertebrate pests such as insects, mites and nematodes, and weeds and diseases. Bayer will sponsor one of the panels focusing on the availability of chemical classes with different modes of action (MoAs).

“It is of utmost importance to design sustainable resistance management strategies,” says Dr. Ralf Nauen, Chief Scientist working on Resistance Management at Crop Science, a division of Bayer.

New legislation has continued to put pressure on the crop protection portfolio in some regions of the world, making the development, registration and commercialization of new solutions more crucial today. In addition, if resistance evolves, the understanding of molecular and genetic mechanisms are important to understand cross-resistance issues in order to implement appropriate resistance management tactics to protect fungicides, herbicides, insecticides and also nematicides.

The field has recently gained momentum through a number of genomic and genetic tools that have allowed dissecting molecular interactions between agrochemicals and interacting proteins, a key topic of this session. Nauen, who is the international lead for the panel, will also present a paper on the bee safety of flupyradifurone (Sivanto™), a modern insecticide from Bayer with an excellent safety profile for the control of major sucking pests.

Bayer will use the event to showcase its commitment to shape agriculture through breakthrough innovation for the benefit of farmers, consumers and the planet. With the passion for innovation shown by Bayer researchers and by working together with scientists around the globe, the company strives to deliver better and more sustainable solutions for all farmers.

Numerous Bayer experts will participate as speakers in the different panels on topics like the discovery and optimization of crop protection products, future challenges in stewardship, regulation and communication, or novel agricultural technologies which include digital solutions and increasing use of biological crop protection products.

Visitors and attending journalists are also invited to meet Bayer at booth 58 in the exhibition hall, where experts will inform about the concept of Tailored Agronomic Solutions, using the latest innovations in chemical and biological crop protection. Visitors can also go on a virtual tour of the Bayer ForwardFarm near Brussels to learn more about state-of-the-art agronomic solutions. The nearby ForwardFarm is a platform to illustrate the commitments of Bayer to both innovation and sustainability.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Download Center
0
file(s) collected

View Download Center